Hypercoagulability and Mortality of Patients with Stroke and Active Cancer: The OASIS-CANCER Study
Mi Ji Lee, Jong-Won Chung, Myung-Ju Ahn, Seonwoo Kim, Jin Myoung Seok, Hye Min Jang, Gyeong-Moon Kim, Chin-Sang Chung, Kwang Ho Lee, Oh Young Bang
J Stroke. 2017;19(1):77-87.   Published online 2016 Dec 12     DOI: https://doi.org/10.5853/jos.2016.00570
Citations to this article as recorded by Crossref logo
Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
Ki-Woong Nam, Chi Kyung Kim, Tae Jung Kim, Sang Joon An, Kyungmi Oh, Sang-Bae Ko, Byung-Woo Yoon
BioMed Research International.2017; 2017: 1.     CrossRef
Treatment of Cryptogenic Stroke with Active Cancer with a New Oral Anticoagulant
Ki-Woong Nam, Chi Kyung Kim, Tae Jung Kim, Sang Joon An, Kyungmi Oh, Sang-Bae Ko, Byung-Woo Yoon
Journal of Stroke and Cerebrovascular Diseases.2017; 26(12): 2976.     CrossRef
Causes of Death in Different Subtypes of Ischemic and Hemorrhagic Stroke
Chi-Hung Liu, Jr-Rung Lin, Chia-Wei Liou, Jiann-Der Lee, Tsung-I Peng, Meng Lee, Tsong-Hai Lee
Angiology.2017; : 000331971773868.     CrossRef